Liraglutide (3mg)
The Original GLP-1 Peptide — Proven & Well-Characterized
Order Liraglutide (3mg) online for laboratory research. Compare the listed vial options and current price, then add your selection to cart and continue to checkout. Review available COA records for the exact product, strength and lot. Research Use Only; not for human or veterinary use.
Liraglutide is listed for glp-1 & metabolic laboratory research. Catalog vial contents are 3mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
Research Applications & Benefits
- Most extensively studied GLP-1 analog
- Gold-standard benchmark compound
- Appetite and glucose regulation
What is Liraglutide?
Liraglutide is a peptide analogue of GLP-1 studied in receptor pharmacology and clinical metabolic research. This catalog lists a 3mg laboratory vial. Vial content is not an administration instruction.
Listed vial contents: 3mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
What mechanisms are being studied?
Liraglutide activates GLP-1 receptors and includes a fatty-acid modification associated with albumin binding. Albumin is a protein in blood. Researchers examine how molecular modifications influence receptor activity and the behavior of a defined formulation.
What are the research questions?
- GLP-1 receptor activity
- Fatty-acid modification and protein binding
- Understanding population-specific cardiovascular and weight-management endpoints
What does the published work describe?
LEADER evaluated cardiovascular outcomes in adults with type 2 diabetes and high cardiovascular risk. SCALE evaluated weight-management outcomes in adults with overweight or obesity. These separate randomized trials answer different clinical questions; neither verifies a research vial.
Experimental models in the cited papers
- LEADER: randomized human cardiovascular-outcomes trial
- SCALE: randomized human weight-management trial
What could future research explore?
Laboratory comparisons can examine how structurally different GLP-1 analogues behave in matched assays. Future treatment questions must distinguish cardiovascular outcomes from weight and glucose endpoints.
These are research directions, not established applications of the product sold here.
What are the limits of this evidence?
Clinical findings apply to the tested formulation, trial population and study conditions. They do not establish the identity, safety or effectiveness of this laboratory vial. Research Use Only: this material is not a finished medicine.
Study references
- Marso SP, et al. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2016. PMID 27295427
- Pi-Sunyer X, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015. PMID 26132939
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
How is Liraglutide handled in the lab?
For Liraglutide, record the product code LIRA-3, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
Choose a solvent for Liraglutide from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay. For a documented lipid-modified construct, evaluate aggregation and adsorption as well as apparent solubility; check compatibility again after dilution into the final assay buffer.
For Liraglutide, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 3751.20 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
Use the documented storage conditions for the supplied Liraglutide form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
A Liraglutide laboratory protocol should record identity, product code LIRA-3, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- Liraglutide
- CAS Number
- 204656-20-2
- Molecular Weight
- 3751.20 g/mol
- HPLC Purity Specification
- ≥98%
- Category
- GLP-1 & Metabolic
- Starting Price
- $79.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
Liraglutide has a catalog purity specification of ≥98%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
Frequently Asked Questions
What is Liraglutide?
Liraglutide is listed for glp-1 & metabolic laboratory research. Catalog vial contents are 3mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
What strengths of Liraglutide are available?
The catalog lists 3mg. These labels describe vial contents, not administration doses. Select the required strength for current pricing and availability; match analysis records to that exact strength and lot.
How should I interpret Liraglutide purity results?
Liraglutide has a catalog purity specification of ≥98%; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use.
How should Liraglutide be handled in the laboratory?
For Liraglutide, record the product code LIRA-3, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
How do I choose a laboratory solvent for Liraglutide?
Choose a solvent for Liraglutide from the documented sequence or chemical identity, salt form and assay requirements. Test a small portion first and record pH, solvent composition and clarity. Do not assume one diluent works for every research material; include a solvent-only control and establish compatibility before using the stock in an assay. For a documented lipid-modified construct, evaluate aggregation and adsorption as well as apparent solubility; check compatibility again after dilution into the final assay buffer.
How do I calculate a Liraglutide stock concentration?
For Liraglutide, calculate mass concentration as measured material mass divided by final solution volume. Calculate molarity only with a documented molecular weight for the supplied chemical form; the catalog lists 3751.20 g/mol as a reference, not lot confirmation. Where available, use matched-lot net content rather than treating chromatographic purity as a mass correction. Record both stock concentration and subsequent dilution factors.
How should Liraglutide be stored after preparation?
Use the documented storage conditions for the supplied Liraglutide form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
What should a Liraglutide lab protocol document?
A Liraglutide laboratory protocol should record identity, product code LIRA-3, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Does Fmoc or Boc synthesis explain this Liraglutide product?
Fmoc and Boc are peptide protecting-group strategies, not proof of how this Liraglutide lot was made. For sequence-defined peptides, synthesis review can examine deletion products, incomplete deprotection and modifications using the method and matching analytical evidence. A single chromatographic peak does not by itself establish sequence.
Is Liraglutide for human use?
No. Liraglutide is strictly Research Use Only. It is not intended for human or veterinary use, diagnosis or treatment. Laboratory handling guidance is not an administration protocol.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
